DOI:
10.1055/s-00034925
Hämostaseologie
LinksClose Window
References
Verstovsek S, Mesa RA, Gotlib J. et al; COMFORT-I Investigators.
Long-term treatment with ruxolitinib for patients with myelofibrosis: 5-year update from the randomized, double-blind, placebo-controlled, phase 3 COMFORT-I trial.
J Hematol Oncol 2017;
10 (01) 55
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.